Histopathological and Molecular Markers in the Assessment of Prostate Cancer Aggressivity
Author:
Publisher
Springer Nature Switzerland
Link
https://link.springer.com/content/pdf/10.1007/978-3-031-51712-9_9
Reference163 articles.
1. Siegel RL, Miller KD, Sandeep Wagle N, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48
2. Chang AJ, Autio KA, Roach M, Scher HI (2014) High-risk prostate cancer: classification and therapy. Nat Rev Clin Oncol 11(6):308–323
3. Hooglang MA, Kweldam CF, van Leenders GJLH (2014) Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review. Biomed Res Int:341324. https://doi.org/10.1155/2014/341324
4. Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M (2010) Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 58(6):831–835
5. Egevald L, Ahmad AS, Algaba F, Berney DM, Boccon-Gibod L, Comperat E et al (2013) Standardization of Gleason grading among 337 European pathologist. Histopathology 62(2):247–256
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3